Roche Holding AG RHHBF OTC

Roche Holding AG (RHHBF) generated $17.84B in operating cash flow for fiscal year 2025. After capital expenditures of $3.75B, free cash flow was $14.09B.

Free cash flow margin was 22.9% of revenue. Cash conversion ratio was 1.38x, indicating earnings are backed by cash.

The company returned $8.39B in dividends and $987.47M in share buybacks to shareholders during the period.

Criteria supported by this page:

• HEALTH (67/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
• MOAT (94/100, Pass) — $14.09B (22.9% FCF margin) supports a durable competitive advantage
• INCOME (85/100) — Cash conversion ratio was 1.38x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 67/100 with 4/7 criteria passed.